ArticleBioinformation2025
Expression analysis of inflammatory cytokines in patients with rheumatoid arthritis.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytokines, such as TNF-α, IL-1, IL-6, and IL-17, are implicated in disease progression, their exact contribution and potential as biomarkers for diagnosis and treatment monitoring in RA patients require further exploration. Therefore, it is of interest to investigate the expression of inflammatory cytokines (TNF-α, IL-1, IL-6, and IL-17) in patients with rheumatoid arthritis (RA). Cytokine levels were measured in both blood and synovial fluid, revealing significant elevation in RA patients compared to healthy controls. A strong correlation between cytokine levels and disease activity was observed, emphasising their role in disease progression. Data show that cytokines could serve as biomarkers for RA diagnosis and for monitoring treatment. Further research is needed to explore targeted therapies based on cytokine profiles. This research advances knowledge by identifying inflammatory cytokines as key biomarkers for disease activity in rheumatoid arthritis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.